相似文献
1
Radiation dose-volume effects in the esophagus.
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S86-93. doi: 10.1016/j.ijrobp.2009.05.070.
2
Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):652-8. doi: 10.1016/j.ijrobp.2004.10.030.
3
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41. doi: 10.1016/s0360-3016(02)03937-8.
4
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):97-103. doi: 10.1016/s0360-3016(99)00163-7.
5
Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Am J Clin Oncol. 2014 Oct;37(5):433-7. doi: 10.1097/COC.0b013e31827de7a2.
6
Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1674-9. doi: 10.1016/j.ijrobp.2011.02.052. Epub 2011 Jun 14.
7
Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy.
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):626-9. doi: 10.1016/j.ijrobp.2005.04.004.
8
Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):100-7. doi: 10.1016/j.ijrobp.2006.04.022. Epub 2006 Jul 12.
9
Acute secondary effects in the esophagus in patients undergoing radiotherapy for carcinoma of the lung.
Am J Clin Oncol. 1989 Feb;12(1):34-40. doi: 10.1097/00000421-198902000-00008.
10
Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer.
Am J Clin Oncol. 2010 Jun;33(3):271-5. doi: 10.1097/COC.0b013e3181a879e0.
引用本文的文献
1
Potential protective regulatory effects on radiation-induced esophageal injury in TUT4 mice.
Front Oncol. 2025 Aug 26;15:1600597. doi: 10.3389/fonc.2025.1600597. eCollection 2025.
2
Esophageal Mucosal Injuries From Drugs, Radiation, and Caustic Agents.
Korean J Helicobacter Up Gastrointest Res. 2025 Jun;25(2):126-133. doi: 10.7704/kjhugr.2025.0023. Epub 2025 Jun 4.
3
A Statistical Approach to Assess Biological Equivalent Mean Organ Dose (MOD) for Different Fractionations in Thoracic Radiotherapy.
Biomedicines. 2025 May 2;13(5):1110. doi: 10.3390/biomedicines13051110.
4
Whole Transcriptome-Based ceRNA Regulatory Network Analysis of Radiation-Induced Esophageal Epithelial Cell Injury.
Biologics. 2025 Apr 22;19:231-249. doi: 10.2147/BTT.S496064. eCollection 2025.
5
Decision tree-based machine learning algorithm for prediction of acute radiation esophagitis.
Biochem Biophys Rep. 2025 Mar 28;42:101991. doi: 10.1016/j.bbrep.2025.101991. eCollection 2025 Jun.
6
Treatment of non-small cell lung cancer: advances following the introduction of PET-CT and IMRT/VMAT.
Strahlenther Onkol. 2025 Mar 6. doi: 10.1007/s00066-025-02377-0.
7
SPECT/CT Dosimetry of Bronchial Artery Tc Macroaggregated Albumin Injection in Pulmonary Malignancies: Feasibility Evaluation of Bronchial Artery Y Radioembolization.
Radiology. 2025 Feb;314(2):e240331. doi: 10.1148/radiol.240331.
8
Comparison of radiation esophagitis associated with daytime versus evening radiotherapy in patients with esophageal carcinoma.
Radiat Oncol. 2025 Jan 8;20(1):3. doi: 10.1186/s13014-024-02575-7.
9
Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancer.
J Natl Cancer Cent. 2021 Feb 18;1(2):31-38. doi: 10.1016/j.jncc.2021.02.003. eCollection 2021 Jun.
10
Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning.
BMC Pulm Med. 2023 Oct 9;23(1):379. doi: 10.1186/s12890-023-02667-2.
本文引用的文献
1
Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
J Thorac Oncol. 2008 Nov;3(11):1279-85. doi: 10.1097/JTO.0b013e31818b1971.
2
Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):810-7. doi: 10.1016/j.ijrobp.2008.04.064. Epub 2008 Aug 26.
3
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S94-100. doi: 10.1097/JTO.0b013e318074de34.
4
Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer.
J Thorac Oncol. 2006 Jun;1(5):434-40.
5
Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration.
Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):775-80. doi: 10.1016/j.ijrobp.2006.09.054.
6
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
J Clin Oncol. 2006 Oct 20;24(30):4833-9. doi: 10.1200/JCO.2006.07.5937.
7
Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):100-7. doi: 10.1016/j.ijrobp.2006.04.022. Epub 2006 Jul 12.
8
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1106-11. doi: 10.1016/j.ijrobp.2006.02.046. Epub 2006 May 26.
9
Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1275-86. doi: 10.1016/j.ijrobp.2005.11.022.
10
Fluoroscopically guided balloon dilation for patients with esophageal stricture after radiation treatment.
J Vasc Interv Radiol. 2005 Dec;16(12):1705-10. doi: 10.1097/01.RVI.0000179813.93992.9E.
Zotero 插件